Pfizer CentreOne is a global contract development and manufacturing organisation (CDMO) specialising in small molecule APIs, highly potent APIs, and sterile injectables.

Pfizer CentreOne leverages over 40 years of manufacturing expertise and is part of Pfizer, a global leader in biopharmaceuticals. The organisation collaborates with pharmaceutical and biotechnology companies to bring innovative therapies to market. With a network of state-of-the-art facilities and a proven track record in regulatory compliance, Pfizer CentreOne is a trusted partner for complex manufacturing challenges. Their expertise spans process development, scale-up, and commercial manufacturing, offering customers seamless support from molecule to market.

Key Products and Services

• Active Pharmaceutical Ingredients (APIs): Custom API development and manufacturing, including highly potent APIs.
• Sterile Injectable Fill-Finish: Advanced sterile manufacturing capabilities for liquid and lyophilised forms.
• Process Development: Comprehensive support for optimising and scaling processes for clinical and commercial use.
• Contract Manufacturing: End-to-end solutions for small molecule drug products, ensuring quality and compliance.
• Regulatory Expertise: Support for regulatory submissions, adhering to global standards.

Pfizer CentreOne combines the agility of a dedicated CDMO with the scale and resources of Pfizer. Their customer-centric approach and commitment to innovation make them a reliable partner for delivering complex therapies. With decades of experience, advanced technologies, and a focus on quality, Pfizer CentreOne helps partners navigate the challenges of pharmaceutical development and manufacturing.